Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CeraPedics and BioD Announce Collaboration Agreement for Development of Orthopedic Products.


LAKEWOOD, Colo. & GERMANTOWN, Tenn. -- CeraPedics LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 and BioD LLC announced today they have signed an agreement to develop products for the orthopedic market using CeraPedics' proprietary P-15(TM) bone graft bone graft Orthopedic surgery Sterilized bony tissue, often of cadaveric origin, used to fill and/or 'sculpt' bone defects Indications Spinal fusion, revision of failed articular prostheses, filling traumatic or malignant bone defects, or periodontal defects.  substitute technology and BioD's proprietary stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 procurement procedure. The companies anticipate that negotiations and planning for the extension of this agreement into a long-term relationship will be finalized after initial feasibility studies are completed.

"We are pleased to enter into this agreement with BioD because of their extensive experience in tissue product procurement and development," said Andrew J. Tofe, Ph.D., Chief Executive Officer of CeraPedics. "BioD understands that human tissue-engineering companies are only as strong as their tissue supply, and their many years of experience in this area ensure a strong foundation for this collaborative effort."

"CeraPedics P-15 bone graft substitute technology provides the ideal environment for use with human stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young  and the potential for development of more effective products than are currently available for orthopedic and spine applications," said Timothy Brahm, Chief Executive Officer of BioD LLC. "CeraPedics P-15 bone graft substitute has demonstrated impressive results in both pre-clinical and pilot clinical orthopedic indications, and we look forward to a mutually beneficial Adj. 1. mutually beneficial - mutually dependent
interdependent, mutualist

dependent - relying on or requiring a person or thing for support, supply, or what is needed; "dependent children"; "dependent on moisture"
 relationship."

Terms of the agreement were not disclosed.

About CeraPedics LLC

CeraPedics LLC, founded in 2000 in Lakewood, Colorado, is a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 with proprietary technology developing a line of bone substitute products and implant coatings that employ the company's small peptide P-15 technology to facilitate bone formation in orthopedic procedures. P-15 was previously approved by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 in 1999 for use in the oral cavity oral cavity
n.
The part of the mouth behind the teeth and gums that is bounded above by the hard and soft palates and below by the tongue and the mucous membrane connecting it with the inner part of the mandible.
. It is estimated that to date nearly a quarter million bone graft procedures have been performed using P-15 bone graft technology in the oral cavity. For more information please visit www.cerapedics.com.

About BioD LLC

BioD LLC is an early-stage tissue engineering company developing proprietary methods for the acquisition and preservation of stem cells derived from tissues discarded by the hospital during birth. Founded in 2005 in Germantown, Tennessee, BioD is a privately held company whose principals have over 40 years' experience in tissue banking which include procurement, processing and distribution.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 19, 2006
Words:355
Previous Article:Blue Ridge Networks(TM) Extends High Security VPN Benefits To More Users Than Ever Before in the Industry; BorderGuard(R) 6800 supports 250,000 users...
Next Article:Nascentric Changes Product Name From Nascim to AuSIM.



Related Articles
REFERENCE BIOMATERIAL FOR ORTHOPEDIC RESEARCH.
CeraPedics to Present at Medtech Insight's ``Investment In Innovation'' Conference.
CeraPedics To Present at Medtech Insight's ``Investment In Innovation'' Conference.
SURGEONS, A.V. FACILITY REACH DEAL.
HOSPITAL SEEKS EMERGENCY ROOM DOC ALTERNATIVES.
CeraPedics L.L.C. to Present at Windhover Information and Medtech Insight's ''In SPINE'' Conference.
ALGERIA - Other Fields.
CeraPedics Announces Addition To its Clinical Advisory Panel.
CeraPedics to Present at Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' Conference, June 21-23, 2006, in San Francisco.
ALGERIA - Guellala & Ben Kahla.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles